- Home
- CYTH vs USEA Comparison
CYTH vs USEA Comparison
Compare CYTH & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTH
- USEA
- Stock Information
- Founded
- CYTH 1990
- USEA 2004
- Country
- CYTH United States
- USEA Greece
- Employees
- CYTH N/A
- USEA N/A
- Industry
- CYTH Biotechnology: Pharmaceutical Preparations
- USEA Marine Transportation
- Sector
- CYTH Health Care
- USEA Consumer Discretionary
- Exchange
- CYTH Nasdaq
- USEA Nasdaq
- Market Cap
- CYTH 20.4M
- USEA 20.0M
- IPO Year
- CYTH N/A
- USEA N/A
- Fundamental
- Price
- CYTH $0.69
- USEA $2.06
- Analyst Decision
- CYTH Buy
- USEA Strong Buy
- Analyst Count
- CYTH 3
- USEA 1
- Target Price
- CYTH $0.95
- USEA $6.00
- AVG Volume (30 Days)
- CYTH 21.2K
- USEA 36.7K
- Earning Date
- CYTH 11-14-2024
- USEA 11-26-2024
- Dividend Yield
- CYTH N/A
- USEA 14.18%
- EPS Growth
- CYTH N/A
- USEA N/A
- EPS
- CYTH N/A
- USEA 0.85
- Revenue
- CYTH $870,725.00
- USEA $46,276,000.00
- Revenue This Year
- CYTH N/A
- USEA $36.03
- Revenue Next Year
- CYTH $24.49
- USEA $11.85
- P/E Ratio
- CYTH N/A
- USEA $2.48
- Revenue Growth
- CYTH N/A
- USEA 86.18
- 52 Week Low
- CYTH $0.59
- USEA $2.05
- 52 Week High
- CYTH $2.12
- USEA $3.00
- Technical
- Relative Strength Index (RSI)
- CYTH 47.10
- USEA 34.90
- Support Level
- CYTH $0.61
- USEA $2.23
- Resistance Level
- CYTH $0.77
- USEA $2.18
- Average True Range (ATR)
- CYTH 0.05
- USEA 0.09
- MACD
- CYTH -0.00
- USEA -0.00
- Stochastic Oscillator
- CYTH 55.63
- USEA 16.13
About CYTH Cyclo Therapeutics Inc.
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.